Connect with us

Technology

Avoiding GenAI Abuse in Copywriting: Anti-PR Strategies to Harness Technology and Unleash Creativity

Published

on

OpenAI’s recent warning about unreliable AI writing detectors carries significant implications for copywriters and marketers, especially as Google intensifies efforts to combat generative AI (GenAI) content. Karla Jo Helms, Chief Evangelist and Anti-PR® Strategist for JOTO PR Disruptors™, notes that while GenAI presents opportunities for greater efficiency and scalability, it also risks “homogenizing” brand voices, potentially undermining their distinctiveness and credibility.

TAMPA BAY, Fla., Sept. 3, 2024 /PRNewswire-PRWeb/ — OpenAI has discontinued its AI classifier, an AI-writing detection tool, citing its low accuracy. Their evaluation of “challenge sets” of written text revealed that the classifier correctly identified only 26% of AI-written content while mislabeling human-written content as AI-written. (1) This has sent ripples through the copywriting industry, as it signals that distinguishing between human and AI-generated content is becoming nearly impossible. Karla Jo Helms, Chief Evangelist and Anti-PR® Strategist for JOTO PR Disruptors™, insists, “This doesn’t diminish the relevance of copywriters but instead emphasizes the need for them to adapt. In an era where AI can produce content at scale, the role of the copywriter evolves from mere content creation to crafting narratives that deeply resonate with human emotions and brand-specific voices.”

“Over-reliance on AI-generated content can lead to a ‘homogenization’ of brand voices, which dilutes their identity, making it difficult for companies to stand out in a crowded marketplace.” — Karla Jo Helms, Chief Evangelist and Anti-PR® Strategist for JOTO PR Disruptors™.

Reshaping Copywriting: 75% of Marketers Turn to GenAI for Scalability
There’s no doubt that generative AI is revolutionizing the marketing industry, transforming how content is both created and delivered.

According to a Salesforce survey, 75% of marketers are already leveraging AI, whether in experimental phases or as a fully integrated part of their workflows. Adobe’s research further underscores this shift, revealing that 83% of creative professionals are actively using GenAi to enhance their work. With the global market value of GenAi projected to soar to nearly $137 billion by 2030, it’s clear that content and creative applications are driving this explosive growth. (2)
GenAi content has proven to be highly efficient and scalable, allowing for the rapid production of content, often completing tasks in minutes that would take writers much longer. This makes it cost-effective, particularly for businesses looking to generate large volumes of content with minimal resources. (3)

The Risks of Abusing GenAI: Homogenization and Loss of Brand Credibility
Its cost-effectiveness has driven GenAI as a growing trend among businesses, with companies increasingly relying on it for content production. However, when it’s not managed correctly, this approach comes with significant risks.

Helms warns that while AI-generated content can streamline processes, it also lacks the originality, creativity, and strategic thinking that human copywriters bring to the table.
“Over-reliance on AI-generated content can lead to a ‘homogenization’ of brand voices, which dilutes their identity, making it difficult for companies to stand out in a crowded marketplace,” she explains.
AI content might also inadvertently introduce biases or factual inaccuracies, which can harm a brand’s credibility by associating it with unoriginal or even fake information.

How AI Empowers Copywriters: Unlocking Creativity and Strategic Potential
Despite the challenges, Helms insists that AI offers copywriters an unprecedented opportunity and, if used wisely, presents them a chance to unleash their full potential as creative professionals.
AI tools can assist in generating ideas, drafting content, and even optimizing for SEO, allowing copywriters to focus on higher-level strategic tasks. This is why the skills that make copywriters relevant—storytelling, emotional intelligence, creativity, and the ability to understand and connect with audiences—are more important than ever.

The Anti-PR Approach to Avoiding Business Risks
In an era where GenAI can produce vast amounts of content, Anti-PR strategies highlight the importance of critical thinking, empathy, and experience in crafting responses that truly resonate with stakeholders. The principles of disruption, authenticity, and narrative control are central to the Anti-PR approach, which emphasizes the need for human-driven storytelling and strategic communication.

“Businesses that blend human creativity with AI efficiency can build strong, unique narratives in a crowded content landscape while those who don’t may risk becoming obsolete, regardless of their innovation or technology,” warns Helms.
The synergy between AI’s data-driven insights and human expertise allows for a more robust and agile approach to crisis management. “In a world increasingly dominated by AI-generated content, this ensures that the uniqueness and authenticity of a brand’s message are preserved and amplified,” concludes Helms.

About JOTO PR Disruptors™
Founded by PR veteran Karla Jo Helms, JOTO PR Disruptors™ emerged from extensive market research with CEOs of fast-growth companies. The agency combines crisis management skills with advanced media algorithms to develop Anti-PR® campaigns. Based in Tampa Bay, Florida, JOTO PR is globally recognized for its innovative Anti-PR services. More information is available at http://www.jotopr.com.

About Karla Jo Helms
Karla Jo Helms is the Chief Evangelist and Anti-PR Strategist for JOTO PR Disruptors™.
She learned firsthand how unforgiving business can be when millions of dollars are on the line—and how the control of public opinion often determines whether one company is happily chosen or another is brutally rejected. Being an alumnus of crisis management, Karla Jo has worked with litigation attorneys, private investigators, and the media to help restore companies of goodwill back into the good graces of public opinion. Helms speaks globally on public relations, how the PR industry itself has lost its way, and how, in the right hands, corporations can harness the power of Anti-PR to drive markets and impact market perception.

References:
1. New Ai Classifier for Indicating AI-Written Text, openai.com/index/new-ai-classifier-for-indicating-ai-written-text. Accessed 27 Aug. 2024.
2. “The Generative AI Statistics Shaping Marketing & Creative in 2024.” The Generative AI Statistics Shaping Marketing & Creative, Superside, 18 July 2024, superside.com/blog/generative-ai-statistics-marketing-creative.
3. Hetler, Amanda. “Pros and Cons of Ai-Generated Content: TechTarget.” WhatIs, TechTarget, 8 July 2024, techtarget.com/whatis/feature/Pros-and-cons-of-AI-generated-content.

Media Contact

Karla Jo Helms, JOTO PR™, 727-777-4629, khelms@jotopr.com, jotopr.com

View original content to download multimedia:https://www.prweb.com/releases/avoiding-genai-abuse-in-copywriting-anti-pr-strategies-to-harness-technology-and-unleash-creativity-302236720.html

SOURCE JOTO PR™

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

on

By

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Continue Reading

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

on

By

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Continue Reading

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

on

By

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system,  helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said  Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company

Continue Reading

Trending